Afatinib in combination with cisplatin and 5-fluorouracil (5-FU) as first line treatment in inoperable gastric and gastro-esophageal junction (GEJ) cancer: A phase II study by the Hellenic Cooperative Oncology Group

被引：0
|
作者：
Makatsoris, T. [1 ]
Samantas, E. [1 ]
Manousou, K. [1 ]
Karavasilis, V. [1 ]
Aravantinos, G. [1 ]
Tryfonopoulos, D. [1 ]
Psyrri, A. [1 ]
Pectasides, D. G. [1 ]
Pazarli, E. [1 ]
Petraki, C. [1 ]
Tsipoura, A. [1 ]
Kaklamanos, I. G. [1 ]
Fountzilas, G. [1 ]
Pentheroudakis, G. [1 ]
机构：
[1] HeCOG, Data Off, Athens, Greece
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
677P
引用
收藏
页数：2
相关论文
共 50 条
  • [21] PHASE-II STUDY OF CISPLATIN, 5-FU, AND ALLOPURINOL IN ADVANCED ESOPHAGEAL CANCER
    DEBESI, P
    SILENI, VC
    SALVAGNO, L
    TREMOLADA, C
    CARTEI, G
    FOSSER, V
    PACCAGNELLA, A
    PERACCHIA, A
    FIORENTINO, M
    CANCER TREATMENT REPORTS, 1986, 70 (07): : 909 - 910
  • [22] Comparison of health-related quality of life with epirubicin, cisplatin plus 5-fluorouracil and docetaxel, cisplatin plus 5-fluorouracil chemotherapy regimens as first-line systemic therapy in locally advanced inoperable or metastatic gastric or gastro-esophageal junction adenocarcinoma: A prospective study from South India
    Babu, K. Govind
    Chaudhuri, Tamojit
    Lakshmaiah, K. C.
    Dasappa, Lokanatha
    Jacob, Linu Abraham
    Babu, M. C. Suresh
    Rudresha, A. H.
    Lokesh, K. N.
    Rajeev, L. K.
    SOUTH ASIAN JOURNAL OF CANCER, 2018, 7 (01) : 11 - 15
  • [23] ASSOCIATION OF CISPLATIN (CDDP) AND 5-FLUOROURACIL (5-FU) IN THE TREATMENT OF SQUAMOUS-CELL CANCER OF THE METASTATIC LUNG (CSPM) - PHASE-II STUDY
    VENTURINI, M
    NICOSIA, F
    VENTURINI, S
    TROIANI, R
    LOMBARDI, M
    SICARI, A
    SPINELLI, I
    TUMORI, 1986, 72 (06) : 736 - 736
  • [24] Phase II study of paclitaxel, cisplatin, and 5-fluorouracil combination chemotherapy in patients with advanced gastric cancer
    Hwang, Junyl
    Cho, Sang-Hee
    Shim, Hyun Jeong
    Lee, Se-Ryeon
    Ahn, Jae Sook
    Yang, Duk-Hwan
    Kim, Yeo-Kyeoung
    Lee, Je-Jung
    Kim, Hyeoung-Joon
    Chung, Ik-Joo
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2008, 23 (04) : 586 - 591
  • [25] Phase II Study of Docetaxel and Cisplatin Chemotherapy in 5-Fluorouracil/Cisplatin Pretreated Esophageal Cancer
    Shim, Hyun-Jeong
    Cho, Sang-Hee
    Hwang, Jun-Eul
    Bae, Woo-Kyun
    Song, Sang-Yun
    Cho, Sung-Bum
    Lee, Wan-Sik
    Joo, Young-Eun
    Na, Kook-Joo
    Chung, Ik-Joo
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2010, 33 (06): : 624 - 628
  • [26] Cisplatin/5-Fluorouracil (5-FU) Versus Carboplatin/Paclitaxel Chemoradiotherapy as Definitive or Pre-Operative Treatment of Esophageal Cancer
    Steber, Cole
    Hughes, Ryan T.
    McTyre, Emory R.
    Soike, Michael
    Farris, Michael
    Levine, Beverly J.
    Pasche, Boris
    Levine, Edward
    Blackstock, Arthur W.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (01)
  • [27] Preliminary safety data from KEYNOTE-059: Pembrolizumab plus 5-fluorouracil (5-FU) and cisplatin for first-line treatment of advanced gastric cancer
    Fuchs, Charles S.
    Ohtsu, Atsushi
    Tabernero, Josep
    Van Cutsem, Eric
    Wang, Jiang Dian
    Lam, Baohoang
    Dalal, Rita
    Koshiji, Minori
    Bang, Yung-Jue
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [28] Phase II study of irinotecan and high dose infusional 5-fluorouracil (5-FU) and folinic acid for first and second line treatment of advanced colorectal cancer.
    Leonard, P
    Ledermann, J
    James, R
    Hochhauser, D
    Seymour, M
    ANNALS OF ONCOLOGY, 2000, 11 : 44 - 45
  • [29] A Phase II Study of 5-Fluorouracil/Leucovorin in Combination with Paclitaxel and Oxaliplatin as First-Line Treatment for Patients with Advanced Gastric Cancer
    Lin, Rong-Bo
    Fan, Nan-Feng
    Guo, Zeng-Qing
    Wang, Xiao-Jie
    Liu, Jie
    Chen, Ling
    JOURNAL OF CHEMOTHERAPY, 2008, 20 (06) : 744 - 748
  • [30] A PHASE I, DOSE-FINDING STUDY OF SUNITINIB (SU) IN COMBINATION WITH CISPLATIN (P) AND 5-FLUOROURACIL (5-FU) IN PATIENTS (PTS) WITH ADVANCED GASTRIC CANCER (GC)
    Gomez-Martin, C.
    Gil-Martin, M.
    Montagut, C.
    Nunez, J. A.
    Salazar, R.
    Puig, M.
    Khosravan, R.
    Tursi, J. M.
    Lechuga, M. J.
    Bellmunt, J.
    ANNALS OF ONCOLOGY, 2010, 21 : 255 - 255
12345